SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Warns Merck & Co., Inc. To Fix Vaccine Plant Problems

May 1, 2008 | 
1 min read
AP -- The Food and Drug Administration has ordered Merck & Co. to correct numerous manufacturing deficiencies at its main vaccine plant, the latest in a string of setbacks for the drugmaker.
Regulatory
Merck & Co. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Vector Illustration Of Athletes Running On Race Track
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Designation
November 21, 2025
 · 
9 min read
 · 
Tristan Manalac
Four miniature figurines of men in casual and formal attire stand around a large stopwatch showing zero, symbolizing time management or competition.
Regulatory
FDA Breakthrough Designations Lead to Priority Reviews, Report Finds
November 20, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Bayer office in Basel, Switzerland
Lung cancer
Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor
November 20, 2025
 · 
1 min read
 · 
Tristan Manalac
FDA commissioner Marty Makary speaking on a Youtube video, wearing a dark suit and a blue tie
FDA
Makary Eyes ‘America-First’ User Fee Structure as Renewal Negotiations Approach
November 19, 2025
 · 
2 min read
 · 
Tristan Manalac